Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans Garmo

Showing results (1-10 of 275) with videos related to

Pageof 28
Sort By:
Gynecologic Oncology|December 23, 2006
Non-genital tract metastases to the ovaries presented as ovarian tumors in Sweden 1990-2003: occurrence, origin and survival compared to ovarian cancerIngiridur Skírnisdóttir, Hans Garmo, Lars Holmberg
The New England Journal of Medicine|March 14, 2019
Radical Surgery or Watchful Waiting in Prostate Cancer. ReplyAnna Bill-Axelson, Lars Holmberg, Hans Garmo
Plos One|October 29, 2020
Prescription-based prediction of baseline mortality risk among older menRolf Gedeborg, Hans Garmo, David Robinson, et al.
BMC Cancer|October 11, 2011
Serum levels of selenium and smoking habits at age 50 influence long term prostate cancer risk; a 34 year ULSAM follow-upBirgitta Grundmark, Björn Zethelius, Hans Garmo, et al.
European Journal of Cancer (Oxford, England : 1990)|January 22, 2008
Risk of second primary malignancies and causes of death in patients with adenocarcinoma and carcinoid of the small intestineNiklas Zar, Hans Garmo, Lars Holmberg, et al.
European Journal of Clinical Pharmacology|March 7, 2014
Reducing the noise in signal detection of adverse drug reactions by standardizing the background: a pilot study on analyses of proportional reporting ratios-by-therapeutic areaBirgitta Grundmark, Lars Holmberg, Hans Garmo, et al.
International Journal of Cancer|July 29, 2008
Borderline ovarian tumors in Sweden 1960-2005: trends in incidence and age at diagnosis compared to ovarian cancerIngiridur Skírnisdóttir, Hans Garmo, Erik Wilander, et al.
Cancer|December 22, 2007
The impact of prostate-specific antigen level at diagnosis on the relative survival of 28,531 men with localized carcinoma of the prostateGabriel Sandblom, Sam Ladjevardi, Hans Garmo, et al.
Statistics in Medicine|September 14, 2006
Correction for regression dilution bias using replicates from subjects with extreme first measurementsLars Berglund, Hans Garmo, Johan Lindbäck, et al.
Plos One|October 16, 2015
Risk of Fractures and Falls during and after 5-α Reductase Inhibitor Use: A Nationwide Cohort StudyDavid Robinson, Hans Garmo, Pär Stattin, et al.
Pageof 28

Showing results (1-10 of 275) with videos related to

Sort By:
Pageof 28
Gynecologic Oncology|December 23, 2006
Non-genital tract metastases to the ovaries presented as ovarian tumors in Sweden 1990-2003: occurrence, origin and survival compared to ovarian cancerIngiridur Skírnisdóttir, Hans Garmo, Lars Holmberg
The New England Journal of Medicine|March 14, 2019
Radical Surgery or Watchful Waiting in Prostate Cancer. ReplyAnna Bill-Axelson, Lars Holmberg, Hans Garmo
Plos One|October 29, 2020
Prescription-based prediction of baseline mortality risk among older menRolf Gedeborg, Hans Garmo, David Robinson, et al.
BMC Cancer|October 11, 2011
Serum levels of selenium and smoking habits at age 50 influence long term prostate cancer risk; a 34 year ULSAM follow-upBirgitta Grundmark, Björn Zethelius, Hans Garmo, et al.
European Journal of Cancer (Oxford, England : 1990)|January 22, 2008
Risk of second primary malignancies and causes of death in patients with adenocarcinoma and carcinoid of the small intestineNiklas Zar, Hans Garmo, Lars Holmberg, et al.
European Journal of Clinical Pharmacology|March 7, 2014
Reducing the noise in signal detection of adverse drug reactions by standardizing the background: a pilot study on analyses of proportional reporting ratios-by-therapeutic areaBirgitta Grundmark, Lars Holmberg, Hans Garmo, et al.
International Journal of Cancer|July 29, 2008
Borderline ovarian tumors in Sweden 1960-2005: trends in incidence and age at diagnosis compared to ovarian cancerIngiridur Skírnisdóttir, Hans Garmo, Erik Wilander, et al.
Cancer|December 22, 2007
The impact of prostate-specific antigen level at diagnosis on the relative survival of 28,531 men with localized carcinoma of the prostateGabriel Sandblom, Sam Ladjevardi, Hans Garmo, et al.
Statistics in Medicine|September 14, 2006
Correction for regression dilution bias using replicates from subjects with extreme first measurementsLars Berglund, Hans Garmo, Johan Lindbäck, et al.
Plos One|October 16, 2015
Risk of Fractures and Falls during and after 5-α Reductase Inhibitor Use: A Nationwide Cohort StudyDavid Robinson, Hans Garmo, Pär Stattin, et al.
Pageof 28